|
| |
| | | 67359 | | 24.03.2020 | | Novartis Pharma Schweiz AG | | | | | | | | | | | | | 07.16.10. | | | | 07.16.10. | | FI |
| | Seq.-Nr. | Präparat | Beschreibung | Galenische Form | ATC-Klassierung | |
|---|
| 02 | Piqray 150 mg | Filmtabletten | Filmtabletten (Alpelisibum 150 mg) | L01EM03 | PI | | 03 | Piqray 200 mg + 50 mg | Filmtabletten | Filmtabletten (Alpelisibum 200 mg) + Filmtabletten (Alpelisibum 50 mg) | L01EM03 | PI | | 04 | Piqray 200 mg | Filmtabletten | Filmtabletten (Alpelisibum 200 mg) | L01EM03 | PI |
|
|
|
